List of bibliographic references
Number of relevant bibliographic references: 59.
[0-20] [
0 - 20][
0 - 50][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000180 (????) |
M. Haarbrink [Pays-Bas] ; A J Terhell ; G K Abadi ; Y. Mitsui ; M. Yazdanbakhsh | Adverse reactions following diethylcarbamazine (DEC) intake in 'endemic normals', microfilaraemics and elephantiasis patients. |
000507 (????) |
D W Meyrowitsch [Danemark] ; P E Simonsen ; P. Magnussen | Tolerance to diethylcarbamazine-medicated salt in individuals infected with Onchocerca volvulus. |
000994 (2002) |
Balachandran Ravindran | Mass drug administration to treat lymphatic filariasis. |
000B21 (2002) |
Taniawati Supali [Indonésie] ; Is Suhariah Ismid ; Paul Rückert ; Peter Fischer | Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae. |
000B43 (2002) |
R K Shenoy [Inde] ; T K Suma ; A. John ; S R Arun ; V. Kumaraswami ; L L Fleckenstein ; K. Na-Bangchang | The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole. |
000B76 (2002) |
Moses J. Bockarie [Papouasie-Nouvelle-Guinée] ; Daniel J. Tisch ; Will Kastens ; Neal D E. Alexander ; Zachary Dimber ; Florence Bockarie ; Ervin Ibam ; Michael P. Alpers ; James W. Kazura | Mass treatment to eliminate filariasis in Papua New Guinea. |
000D83 (2003) |
Steven I. Mclaughlin [États-Unis] ; Jeanne Radday ; Marie Carmel Michel ; David G. Addiss ; Michael J. Beach ; Patrick J. Lammie ; John Lammie ; Richard Rheingans ; Jack Lafontant | Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000. |
000F23 (1992) |
H J Zheng [République populaire de Chine] ; W F Piessens ; Z H Tao ; W F Cheng ; S H Wang ; S Z Cheng ; Y M Ye ; L F Luo ; X R Chen ; G B Gan | [Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitological observations]. |
001708 (2003) |
| Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis. |
001753 (1992) |
P C Fan [République populaire de Chine] | Diethylcarbamazine treatment of bancroftian and malayan filariasis with emphasis on side effects. |
001845 (1992) |
J L Cartel [Polynésie française] ; A. Spiegel ; L. Nguyen ; J P Moulia-Pelat ; P M Martin ; J F Roux | [Comparative efficacy of annual and semi-annual doses of ivermectin or diethylcarbamazine for the prevention of lymphatic filariasis]. |
001951 (2004) |
N A Kshirsagar [Inde] ; N J Gogtay ; B S Garg ; P R Deshmukh ; D D Rajgor ; V S Kadam ; B G Kirodian ; N S Ingole ; A M Mehendale ; L. Fleckenstein ; J. Karbwang ; J K Lazdins-Helds | Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India. |
001A21 (2004) |
B V Babu [Inde] ; S K Kar | Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India. |
001A94 (????) |
Joaquim Noroes [Brésil] ; David Addiss ; Agnaldo Cedenho ; Jose Figueredo-Silva ; Guilherme Lima ; Gerusa Dreyer | Pathogenesis of filarial hydrocele: risk associated with intrascrotal nodules caused by death of adult Wuchereria bancrofti. |
001C42 (1992) |
J. Liu [République populaire de Chine] ; Z. Chen ; X. Huang ; Z. Tu | Mass treatment of filariasis using DEC-medicated salt. |
001E00 (2005) |
P. Vanamail [Inde] ; K D Ramaiah ; S. Subramanian ; S P Pani ; J. Yuvaraj ; P K Das | Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India. |
001E52 (2005) |
Kapa D. Ramaiah ; Rengachari Ravi ; Pradeep K. Das | Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis. |
002026 (2006) |
B V Babu [Inde] ; K. Rath ; A S Kerketta ; B K Swain ; S. Mishra ; S K Kar | Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India. |
002057 (1992) |
M. Yazdanbakhsh ; L. Duym ; L. Aarden ; F. Partono | Serum interleukin-6 levels and adverse reactions to diethylcarbamazine in lymphatic filariasis. |
002138 (2004) |
S P Pani ; G Subramanyam Reddy ; P. Vanamail ; N. Venkatesvarlou ; L K Das ; A P Vijayan | Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India. |
002205 (2005) |
S P Pani ; L K Das ; P. Vanamail | Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF). |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Diethylcarbamazine (adverse effects)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i \
-Sk "Diethylcarbamazine (adverse effects)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= KwdEn.i
|clé= Diethylcarbamazine (adverse effects)
}}
| This area was generated with Dilib version V0.6.31. Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024 | |